Key result
Tunicate heparan sulfate shows ~11-fold greater potency than heparin at inhibiting tumor P-selectin binding.
Effect estimate: 11-fold more potent
Investigates the anticoagulant activity and tumor cell binding inhibition of tunicate heparan sulfate, suggesting evolutionary significance.
Heparin or highly sulfated heparan sulfate (HS) has been described in different invertebrates. In ascidians (Chordata-Tunicata), these glycosaminoglycans occur in intracellular granules of oocyte accessory cells and circulating basophil-like cells, resembling mammalian mast cells and basophils, respectively. HS is also a component of the basement membrane of different ascidian organs. We have analyzed an HS isolated from the internal organs of the ascidian Phallusia nigra, using solution 1H/13C NMR spectroscopy, which allowed us to identify and quantify the monosaccharides found in this glycosaminoglycan. A variety of α-glucosamine units with distinct degrees of sulfation and N-acetylation were revealed. The hexuronic acid units occur both as α-iduronic acid and β-glucuronic acid, with variable sulfation at the 2-position. A peculiar structural aspect of the tunicate HS is the high content of 2-sulfated β-glucuronic acid, which accounts for one-third of the total hexuronic acid units. Another distinct aspect of this HS is the occurrence of high content of N-acetylated α-glucosamine units bearing a sulfate group at position 6. The unique ascidian HS is a potent inhibitor of the binding of human colon adenocarcinoma cells to immobilized P-selectin, being 11-fold more potent than mammalian heparin, but almost ineffective as an anticoagulant. Thus, the components of the HS structure required to inhibit coagulation and binding of tumor cells to P-selectin are distinct. Our results also suggest that the regulation of the pathway involved in the biosynthesis of glycosaminoglycans suffered variations during the evolution of chordates.
No takes yet. Share an insight, caveat, or question.
Abreu et al. (2019) studied this question. Tunicate heparan sulfate from Phallusia nigra vs. Mammalian heparin was evaluated on Inhibition of the binding of human colon adenocarcinoma cells to immobilized P-selectin (11-fold more potent). Tunicate heparan sulfate was 11-fold more potent than mammalian heparin at inhibiting human colon adenocarcinoma cell binding to P-selectin, though almost ineffective as an anticoagulant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: